Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q04DX004 (ip) |
mean tumor weight change |
saline |
2.5 mg/kg/injection |
-53.0 |
Antitumor endpoint evaluated on day 18; 05/05 animals surviving on day 18 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
2.5 mg/kg/injection |
2.0 |
Antitumor endpoint evaluated on day 18; 06/06 animals surviving on day 18 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
5.0 mg/kg/injection |
-88.0 |
Antitumor endpoint evaluated on day 18; 06/06 animals surviving on day 18 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
5.0 mg/kg/injection |
2.0 |
Antitumor endpoint evaluated on day 18; 06/06 animals surviving on day 18 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
10.0 mg/kg/injection |
-98.0 |
Antitumor endpoint evaluated on day 18; 06/06 animals surviving on day 18 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
10.0 mg/kg/injection |
-66.0 |
Antitumor endpoint evaluated on day 18; 05/05 animals surviving on day 18 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
20.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 18; 01/06 animals surviving on day 18 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
20.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 18; 00/06 animals surviving on day 18 |